These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30516668)
1. 18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases. Cuppari L; Reccia P; Burei M; Cervino AR; Evangelista L Clin Nucl Med; 2019 Feb; 44(2):e96-e97. PubMed ID: 30516668 [TBL] [Abstract][Full Text] [Related]
2. Brain 18F-choline PET/CT in primary diffuse leptomeningeal melanomatosis. Jacob M; Delfort F; Heliette C; Renard D Acta Neurol Belg; 2016 Dec; 116(4):647-648. PubMed ID: 27085711 [No Abstract] [Full Text] [Related]
3. Intracranial Leptomeningeal Carcinomatosis from Breast Cancer Detected on 18F-FDG PET. Carra BJ; Clemenshaw MN J Nucl Med Technol; 2015 Sep; 43(3):227-8. PubMed ID: 25655343 [TBL] [Abstract][Full Text] [Related]
4. 18F-FES PET/CT for Characterization of Brain and Leptomeningeal Metastasis in Double Primary Cancer Patient. Lee Y; Yoo IR; Ha S Clin Nucl Med; 2022 Aug; 47(8):e554-e556. PubMed ID: 35797633 [TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal carcinomatosis: easy to miss. Sekhar A; Corbo B; Das K; Biswas S J R Coll Physicians Edinb; 2017 Dec; 47(4):351-352. PubMed ID: 29537406 [TBL] [Abstract][Full Text] [Related]
6. Leptomeningeal Metastasis in Carotid Body Paraganglioma: Findings on 68Ga DOTANOC PET-CT. Tripathy S; Damle NA; Naranje P; Shamim SA; Tripathi M; Bal C Clin Nucl Med; 2019 Oct; 44(10):e583-e585. PubMed ID: 31348087 [TBL] [Abstract][Full Text] [Related]
7. 68Ga-DOTATOC PET/CT and MR in the Evaluation of Meningeal Metastasis From Esthesioneuroblastoma: A Case Report. Dondi F; Albano D; Bertoli M; Bertagna F; Giubbini R Clin Nucl Med; 2021 Jul; 46(7):e378-e380. PubMed ID: 33782294 [TBL] [Abstract][Full Text] [Related]
8. Diffuse cortical hypermetabolism of the cerebellum in meningeal carcinomatosis: Assessment with Crombé A; Cazeau AL; Cousin S; Chomy F; Bacci J; Kind M Diagn Interv Imaging; 2019 Dec; 100(12):821-823. PubMed ID: 31047839 [No Abstract] [Full Text] [Related]
9. Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis. Chen IC; Lin CH; Jan IS; Cheng AL; Lu YS J Formos Med Assoc; 2016 Apr; 115(4):243-8. PubMed ID: 25890495 [TBL] [Abstract][Full Text] [Related]
10. 68Ga-FAPI PET/CT in Assessment of Leptomeningeal Metastases in a Patient With Lung Adenocarcinoma. Hao B; Wu J; Pang Y; Sun L; Chen H Clin Nucl Med; 2020 Oct; 45(10):784-786. PubMed ID: 32796242 [TBL] [Abstract][Full Text] [Related]
11. [Leptomeningeal carcinomatosis following 27 years remission from breast cancer with epidermoid: a case report]. Tajima Y; Horiguchi K; Nakano S; Hirono S; Higuchi Y; Oide T; Iwadate Y; Saeki N No Shinkei Geka; 2012 Apr; 40(4):343-9. PubMed ID: 22466234 [TBL] [Abstract][Full Text] [Related]
12. MRI based neuroanatomical segmentation in breast cancer patients: leptomeningeal carcinomatosis vs. oligometastatic brain disease vs. multimetastastic brain disease. Mayinger M; Reibelt A; Borm KJ; Ettl J; Wilkens JJ; Combs SE; Oechsner M; Duma MN Radiat Oncol; 2019 Sep; 14(1):170. PubMed ID: 31533742 [TBL] [Abstract][Full Text] [Related]
13. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape. Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925 [TBL] [Abstract][Full Text] [Related]
14. [Effective systemic palliative chemotherapy for intracranial metastases of breast cancer]. Sipőcz I; Pintér T; Skaliczky Z; Kullmann T Orv Hetil; 2016 Nov; 157(45):1809-1813. PubMed ID: 27817234 [TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Incidentally Detected by 18F-Choline PET/CT in a Patient With Recurrent Prostate Carcinoma. Vadrucci M; Gilardi L; Grana CM Clin Nucl Med; 2016 Nov; 41(11):892-893. PubMed ID: 27607157 [TBL] [Abstract][Full Text] [Related]
16. The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis. Lee YC; Hsieh CC; Chuang JP; Li CY Curr Probl Cancer; 2017; 41(5):355-370. PubMed ID: 28779849 [TBL] [Abstract][Full Text] [Related]
17. Hashimoto's encephalopathy as the cause of deteriorating consciousness during treatment of leptomeningeal carcinomatosis from breast cancer. Liang YH; Wu PF; Lin CH; Lu YS J Clin Oncol; 2012 Nov; 30(33):e358-9. PubMed ID: 23045590 [No Abstract] [Full Text] [Related]
18. Leptomeningeal carcinomatosis can be presenting manifestation of breast carcinoma. Stojmenović GM; Pavlović AM; Gazibara MS; Grujicić D; Radojicić A; Sternić NC Vojnosanit Pregl; 2016 Mar; 73(3):293-5. PubMed ID: 27295918 [TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin. Salgia S; Fleming GF; Lukas RV J Clin Neurosci; 2014 Jul; 21(7):1250-1. PubMed ID: 24412296 [TBL] [Abstract][Full Text] [Related]
20. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis. Park WY; Kim HJ; Kim K; Bae SB; Lee N; Lee KT; Won JH; Park HS; Lee SC Cancer Res Treat; 2016 Apr; 48(2):843-7. PubMed ID: 25761487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]